靶向ERFE N端结构域抗体可阻止铁调素抑制并改善小鼠地中海贫血
本研究开发了针对红铁酮(ERFE)的抗体,旨在阻止铁调素抑制并纠正β-地中海贫血小鼠模型的铁过载表型。研究发现ERFE以纳摩尔级亲和力直接结合BMP6,且其N端结构域足以抑制铁调素;靶向该结构域的抗体可阻止ERFE-BMP6相互作用,并改善Hbb(th3/+)小鼠的脾肿大、血清和肝脏铁,同时升高红细胞和血红蛋白、降低网织红细胞计数。
要点
- ERFE以纳摩尔级亲和力直接结合BMP6,并较弱地结合BMP2和BMP4。
- ERFE的N端结构域足以在Huh7细胞和野生型小鼠中抑制铁调素。
- 靶向ERFE N端结构域的抗体可改善β-地中海贫血小鼠的铁过载和贫血表型。
核心结论
- ERFE直接以高亲和力结合BMP6,靶向其N端结构域以阻断ERFE-BMP6相互作用的抗体是铁过载性贫血的潜在治疗工具。
研究设计与样本
- 研究在β-地中海贫血小鼠模型Hbb(th3/+)中开发抗ERFE抗体,并使用这些抗体作为工具进一步表征ERFE的作用机制。
主要发现
- ERFE以纳摩尔级亲和力结合BMP6,并较弱地结合BMP2和BMP4。
- BMP6结合ERFE的N端结构域,源自ERFE N端的多肽足以在Huh7肝癌细胞和野生型小鼠中引起铁调素抑制。
- 靶向N端结构域的抗ERFE抗体在ERFE处理的Huh7细胞和EPO处理的小鼠中阻止铁调素抑制。
- 抗ERFE治疗的Hbb(th3/+)小鼠脾肿大减轻,血清和肝脏铁降低,红细胞和血红蛋白升高,网织红细胞计数降低。
临床怎么用
- 靶向ERFE N端结构域以阻断ERFE-BMP6相互作用的抗体策略,可能用于铁过载性贫血(如β-地中海贫血)的治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Erythroferrone (ERFE) is produced by erythroblasts in response to erythropoietin (EPO) and acts in the liver to prevent hepcidin stimulation by BMP6. Hepcidin suppression allows for the mobilization of iron to the bone marrow for the production of red blood cells. Aberrantly high circulating ERFE in conditions of stress erythropoiesis, such as in patients with β-thalassemia, promotes the tissue iron accumulation that substantially contributes to morbidity in these patients. Here we developed antibodies against ERFE to prevent hepcidin suppression and to correct the iron loading phenotype in a mouse model of β-thalassemia [Hbb(th3/+) mice] and used these antibodies as tools to further characterize ERFE's mechanism of action. We show that ERFE binds to BMP6 with nanomolar affinity and binds BMP2 and BMP4 with somewhat weaker affinities. We found that BMP6 binds the N-terminal domain of ERFE, and a polypeptide derived from the N terminus of ERFE was sufficient to cause hepcidin suppression in Huh7 hepatoma cells and in wild-type mice. Anti-ERFE antibodies targeting the N-terminal domain prevented hepcidin suppression in ERFE-treated Huh7 cells and in EPO-treated mice. Finally, we observed a decrease in splenomegaly and serum and liver iron in anti-ERFE-treated Hbb(th3/+) mice, accompanied by an increase in red blood cells and hemoglobin and a decrease in reticulocyte counts. In summary, we show that ERFE binds BMP6 directly and with high affinity, and that antibodies targeting the N-terminal domain of ERFE that prevent ERFE-BMP6 interactions constitute a potential therapeutic tool for iron loading anemias.
引用
- Arezes J, Foy N, McHugh K, et al. Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia. Blood. 2020. PMID: 31899794. doi:10.1182/blood.2019003140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。